Literature DB >> 23642972

Variance of melatonin and cortisol rhythm in patients with allergic rhinitis.

Vural Fidan1, Hamit Hakan Alp, Mustafa Gozeler, Onder Karaaslan, Omer Binay, Cemal Cingi.   

Abstract

OBJECTIVE: Allergic rhinitis is an IgE-mediated inflammatory disease which effects 10%-50% of the normal population. The mechanism of its formation and the circadian rhythm of cortisol and melatonin in allergic rhinitis have not been investigated. STUDY
DESIGN: Salivary levels of melatonin and cortisol were measured by radioimmunoassay in 35 newly diagnosed allergic rhinitis patients and in 23 control subjects matched for age and gender.
RESULTS: In the study group; amplitude, baseline and peak levels of salivary melatonin were significantly decreased compared with healty controls (p<0.001). No differences were found in the acrophase and the peak duration of salivary melatonin between the study and control groups (p>0.05). In the study subjects, the circadian rhythm of cortisol was flattened when compared with the control group. The amplitude and the 24h mean levels of salivary cortisol in the study group were significantly lower than in the control group and the acrophase was delayed in patients compared with control subjects (p<0.001).
CONCLUSION: The circadian rhythms of salivary melatonin and cortisol were found to be disrupted in patients with allergic rhinitis. These results may also be contributive data to explain the pathogenesis of allergic rhinitis and also they can be applicable as adjunctive therapeutic tools in the future and melatonin drugs might be an alternative in the therapy of resistant allergic rhinitis patients or allergic rhinitis patients who cannot use cortisol drugs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23642972     DOI: 10.1016/j.amjoto.2013.03.004

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  7 in total

Review 1.  Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis.

Authors:  Emma K Adam; Meghan E Quinn; Royette Tavernier; Mollie T McQuillan; Katie A Dahlke; Kirsten E Gilbert
Journal:  Psychoneuroendocrinology       Date:  2017-05-24       Impact factor: 4.905

2.  Associations of sleep problems with asthma and allergic rhinitis among Chinese preschoolers.

Authors:  Ying Ma; Jie Tang; Yuqi Wen; Yan Hu; Jingjing Liang; Lin Jiang; Yanfei Xing; Yanyan Song
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

3.  Period2 gene regulates diurnal changes of nasal symptoms in an allergic rhinitis mouse model.

Authors:  Feng-Li Cheng; Yun-Fang An; Zhuo-Qin Han; Chao Li; Ze-Qing Li; Ping-Chang Yang; Chang-Qing Zhao
Journal:  Int Forum Allergy Rhinol       Date:  2020-07-01       Impact factor: 3.858

Review 4.  Could melatonin have a potential adjuvant role in the treatment of the lasting anosmia associated with COVID-19? A review.

Authors:  Ellen M S Xerfan; Priscila K Morelhao; Felipe H Arakaki; Anamaria da Silva Facina; Jane Tomimori; Sandra D Xavier; Sergio Tufik; Monica L Andersen
Journal:  Int J Dev Neurosci       Date:  2022-07-23       Impact factor: 2.540

Review 5.  Biological clocks: their relevance to immune-allergic diseases.

Authors:  Roberto Paganelli; Claudia Petrarca; Mario Di Gioacchino
Journal:  Clin Mol Allergy       Date:  2018-01-10

6.  Assessment of Different Cetirizine Dosing Strategies on Seasonal Allergic Rhinitis Symptoms: Findings of Two Randomized Trials.

Authors:  Eduardo R Urdaneta; Mitesh K Patel; Kathleen B Franklin; Xiaoyan Tian; Mei-Miau Wu
Journal:  Allergy Rhinol (Providence)       Date:  2018-07-13

7.  Cognitive dysfunction and quality of life during pollen season in children with seasonal allergic rhinitis.

Authors:  Georgia Papapostolou; Hampus Kiotseridis; Kerstin Romberg; Åslög Dahl; Leif Bjermer; Magnus Lindgren; David Aronsson; Alf Tunsäter; Ellen Tufvesson
Journal:  Pediatr Allergy Immunol       Date:  2020-08-31       Impact factor: 5.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.